See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Research Area · Cell Cycle

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
13828 3-Deazaneplanocin A 102052-95-9 ≥98% 2011-02-18 231.492454617205 3-deazaneplanocin-a DZNep; NSC 617989 EZH2 KMT6 methyltransferases histones cancer epigenetics panobinostat 3deazaneplanocin 3-cyclopentene-1,2-diol deriv Adenosine Adenocard 231.492454617205
10495 4-iodo-SAHA 1219807-87-0 ≥98% 2011-01-10 21.372640883977 4-iodo-saha anti-cancers HDACs inhibitors anti-proliferation 4-Hydroxy-5-iodo-3-nitrophenyl)acetyl 4-Hydroxy-3-iodo-5-nitrophenyl)acetyl 5-Iodo-4-hydroxy-3-nitrophenacetyl 5 Iodo 4 hydroxy 3 nitrophenacetyl Nitrohydroxyiodophenylacetate Hydroxyiodonitrophenylacetate Hapten NIP Acetyl Acetyl Hapten NIP NIP Acetyl Hapten NIP-Hapten NIP Hapten 21.372640883977
13145 AGK2 304896-28-4 ≥98% 2009-10-22 11.670718232044 agk2 sirtuins SIRT2 histones deacetylase HDAC cells cycle progression tumorigenesis cancers SIRT1 SIRT3 dopamine neurons α-synuclein Parkinson's diseases neurodegeneration 11.670718232044
11491 AZD 7762 New 860352-01-8 ≥98% 2012-04-11 51.111111111111 azd-7762 1019773-80-8 DNA damage repair checkpoints cells cycles kinases Chk1 Chk2 S phases G2 tumors cancers inhibitors inhibits inhibition AZD-7762 AZD7762 ATP Chk-1 Chk-2 Chk 1 Chk 2 51.111111111111
13123 BIO 667463-62-9 ≥98% 2009-06-09 39.414977398292 bio GSK 3 IX; MLS 2052 GSK-3α GSK-3β inhibitors Cdk cells cycle wnt ESCs differentiation embryonic stem GSK-3a/b GSK3a/b 39.414977398292
13299 Bisindolylmaleimide IV 119139-23-0 ≥98% 2009-07-29 12.639200145022 bisindolylmaleimide-iv Arcyriarubin A PKC PKA staurosporine inhibitors 634199-73-8 12.639200145022
13013 (−)-Blebbistatin 856925-71-8 ≥98% 2009-04-16 25.285276243094 -blebbistatin (S)-Blebbistatin inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light blebs (-)-(S)-Blebbistatin 25.285276243094
13165 (+)-Blebbistatin - ≥98% 2009-04-16 15.714917127072 -blebbistatin (R)-Blebbistatin inhibitors muscles myosin ATPase smooth muscle bleb apoptosis cell migration chemotaxis cytokinesis cells division growth UV light (+)-(R)-Blebbistatin inhibition inhibited 15.714917127072
13186 (±)-Blebbistatin 674289-55-5 ≥98% 2009-06-09 62.848453038674 -blebbistatin inhibitors muscles myosin ATPase smooth bleb apoptosis cells migration chemotaxis cytokinesis division growth UV lights 62.848453038674
13497 BRD4/HUNK1 Polyclonal Antibody - 2009-09-22 7.241528592657 brd4-hunk1-polyclonal-antibody BET antibodies WB western blots blotting immunoblotting terminus isoforms 7.241528592657
10007955 CAY10498 863202-33-9 ≥98% 2006-08-02 41.749779005525 cay10498 2-phenyl-amino-N6-endo-norbornyladenine adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology 41.749779005525
10008872 CAY10503 - ≥98% 2007-08-02 80.509723756906 cay10503 apoptosis antiproliferation cancers differentiation HL60 cells cycles proliferative positive markers CD14 CD11b CD11c monocytic granulocytic 80.509723756906
10010301 CAY10554 267654-00-2 ≥95% 2007-12-01 10.028232044198 cay10554 BML-259 cell cycle cdk5 cdk2 inhibitors inhibits inhibition cancers BML 259 BML259 CDKs neurodegenerative diseases 10.028232044198
10010043 CAY10561 Exclusive 933786-58-4 ≥98% ✓ 2008-03-06 13.732486187846 cay10561 Pyrazolylpyrrole ERK Inhibitor MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors 13.732486187846
10011247 CAY10574 140651-18-9 >95% 2008-09-04 13.999403314917 cay10574 CDK2 cyclin E CDK9 inhibitors inhibits inhibition anticancer cell cycle CAN508 13.999403314917
10011256 CAY10577 300675-28-9 ≥95% 2008-09-02 0.613259668508 cay10577 inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers 0.613259668508
10011264 CAY10578 19231-60-8 ≥95% 2008-08-26 0.613259668508 cay10578 inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids 0.613259668508
13836 CAY10625 137346-42-0 ≥95% 2010-06-23 2.702464088397 cay10625 apoptosis Smac Diablo Survivin cancers antagonists INCENP doxorubicin caspase-3 caspase-7 Aurora B kinases Borealin caspases cell-permeable antagonists smac/diable smac-diablo 2.702464088397
10009349 Cell Cycle Phase Determination Kit - 2007-04-20 66.600055248619 cell-cycle-phase-determination-kit assays kits measures measurements microscopy flow cytometry plate readers regulators cells transcription factors DNA proteins division proliferation induction inhibition fixation permeabilization staining sub-G1 G0 G2 S propidium iodide apoptosis cancer cell-based assay cell based assay cba 66.600055248619
10009853 CFSE Cell Division Assay Kit - 2010-01-15 63.844708882277 cfse-cell-division-assay-kit derivative carboxyfluorescein diacetate, succinimidyl ester CFDA-SE cells proliferation growth factors receptors surfaces signaling molecules transcription factors DNA deoxyribonucleases proteins divisions cascades human pathological diseases cancers cell-tracing fluorescent fluorescence dyes proliferative activity parent generations daughter acetate groups molecules cleaved background unstained staining CFSE-labeled radioactivity radioactive labeling divisions inductions inhibitors inhibits inhibitions in vitro models flow cytometry fluorochromes fluorescein 63.844708882277
9000760 Colchicine 64-86-8 ≥98% 2011-05-25 19.853603437692 colchicine microtubules polymerization mitosis anti-proliferation anti-inflammatory gout uric acids antiinflammatory antiproliferation 19.853603437692
10010706 (−)-Deguelin 522-17-8 ≥98% 2008-09-18 42.460497237569 -deguelin (-)-cis-Deguelin rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K 42.460497237569
10008422 D-myo-Inositol-1,5,6-triphosphate (sodium salt) 120965-76-6 ≥98% 2009-08-04 24.697269797421 d-myo-inositol-1-5-6-triphosphate-sodium-salt Ins(1,5,6)-P3 (sodium salt); 1,5,6-IP3 (sodium salt) phosphates IP2 signal transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositol IP3 second messengers trisphosphates PtdIns phosphatidylinositol D-myos PIPS 24.697269797421
10008419 D-myo-Inositol-2,4-diphosphate (sodium salt) - ≥98% 2009-08-04 26.105584714548 d-myo-inositol-2-4-diphosphate-sodium-salt Ins(2,4)-P2 (sodium salt); 2,4-IP2 (sodium salt) phosphates IP2 signals transduction cells cycling apoptosis differentiation motility InsP phosphatidyl inositols IP3 second messengers biphosphates bisphosphates PtsIns phosphatidylinositol 106358-02-5 26.105584714548
10010302 DRB 53-85-0 ≥98% 2008-01-21 4.993093922652 drb Benzimidazole; NSC 401575 cancers HIV P53 apoptosis CDK7 CDK9 CTD CKI CKII adenosine inhibitors inhibits inhibition transcription RNA polymerase cell cycles adenocarcinoma transactivator tat 4.993093922652
10924 Epothilone B 152044-54-7 ≥95% 2011-07-27 21.490939226520 epothilone-b macrolides inhibitors inhibits inhibition tubulin microtubules polymerization cancers cells cycle mitotic arrest mitosis Hs578T HeLa KB3-1 KB31 KBV-1 KBV1 cytoskeletal 21.490939226520
10007806 Epoxomicin 134381-21-8 ≥98% 2008-12-09 57.390685082873 epoxomicin BU 4061T inhibitors inhibits inhibition proteins degradation 20S proteasomes antitumors bones formation Parkinsons diseases anti-tumors 57.390685082873
10010238 Erbstatin Analog 63177-57-1 ≥98% 2008-06-06 0.437569060774 erbstatin-analog Methyl 2,5-dihydoxycinnamate analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers 0.437569060774
13355 Geldanamycin 30562-34-6 ≥98% 2010-07-29 35.265105447297 geldanamycin NSC 122750 NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors 2,5-Cyclohexadiene-1,4-Diones 1,4-Benzoquinones 1,2-Benzoquinones p-Benzoquinones-o-Benzoquinones Benzoquinones Benzodiones Quinones geldanomycin GDM NSC122750 NSC-122750 NSC 122750 AC-6794 BRN 1633093 geldanamicin 30562-34-6 antibiotic U29135 U-29135 U 29135 AC1NQZ81 ligands GRP94 Hsp 90 35.265105447297
600450 Glycolysis Cell-Based Assay Kit Exclusive - ✓ 2011-08-18 111.060715804774 glycolysis-cell-based-assay-kit CBAs assays kits measures colorimetric colorimetric-based L-lactate culture media mediums cellular metabolic pathways glucose metabolisms cells ATP adenosines triphosphates oxygen exercise erythrocytes mitochondria glucoeogenesis intracellular molecules amino acids insulin glycolytic neurons aerobic energy muscles anaerobic cancers lactate pyruvate tricarboxylic acids cycles oxidizes carbon dioxide CO2 water H2O tumor aggressiveness embryonic stem activity hypoxia-inducible transcriptional factors HIF-1 extracellular inhibition inhibits inhibitors chemotherapeutic strategies strategy metabolomic drugs discovery anticancer 111.060715804774
10009231 HDAC1 (human recombinant) - >10% by SDS-PAGE 2006-12-06 28.775327141220 hdac1-human-recombinant Histone Deacetylase 1 HDAC 1 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus GST-tagged baculovirus Sf9 active 28.775327141220
10009377 HDAC2 (human recombinant) - ≥70% by SDS-PAGE 2006-12-06 23.566802079947 hdac2-human-recombinant Histone Deacetylase 2 HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active 23.566802079947
10009232 HDAC3/NCOR2 (human recombinant) - ≥50% 2006-12-06 38.905749309392 hdac3-ncor2-human-recombinant Histone Deacetylase 3 HDAC 3 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active 38.905749309392
10009379 HDAC5 (human recombinant) - ≥90% by SDS-PAGE 2006-12-06 32.033977900551 hdac5-human-recombinant Histone Deacetylase 5 HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 active 32.033977900551
16834 Hexadecanal-d5 - ≥99% deuterated forms (d1-d5) 2009-03-02 63.429475138121 hexadecanal-d5 Palmitaldehyde; 16-Hexadecanal deuterated deuterium sphingosine-1-phosphate S1P palmitic acids S1P lyase 1 plasmalogen cell proliferation GC/MS GC-MS LC/MS LC-MS mass spectrometry 63.429475138121
10202 Hsp90α (human recombinant) - ≥80% 2010-03-16 5.324861878452 hsp90-human-recombinant Hsp86; Heat Shock Protein 90α heat shock proteins molecular chaperones Hsp90.alpha. Hsp90AA1 HspCAL4 HspN 90kDa cytosolic class A member 2 heat-shock 1 Hsp90AA2 Hsp86 Hsp90a active 5.324861878452
10342 Hsp90β (human recombinant) - ≥85% 2010-03-16 4.351576210594 hsp90-human-recombinant Hsc90; Heat Shock Protein 90β; Hsp90 AB1 heat shock proteins molecular chaperones Hsp90.beta. 90kDa alpha cytosolic class B member 1 Hsp90beta Hsp90AB1 Hsp90b active 4.351576210594
13325 Iso-Olomoucine 101622-50-8 ≥98% 2011-07-27 0.331546961326 iso-olomoucine cyclin dependent kinases Cdks cells cycles dopamine inhibitors inhibits inhibition inactive controls regulators iso olomoucine transporter diseases neurodegenerative signaling rats dorsal striatal synaptosomes cancers neuroscience 0.331546961326
13712 KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A-23) - 2009-12-02 0E-12 kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated 0E-12
10010239 Kenpaullone 142273-20-9 ≥98% 2007-09-04 13.485745856354 kenpaullone NSC 664704; 9-Bromopaullone GSK-3.beta. cyclin-dependent kinase cyclin CDK inhibitors inhibits inhibition proliferations cell cycle cancers 13.485745856354
9000332 Methylcarbamyl PAF C-8 Exclusive - ≥98% ✓ 2009-02-25 11.841353591160 methylcarbamyl-paf-c-8 Methylcamyl PAF Methylcamyl PAF C-8 Methylcamyl PAF C-16 PAF C-16 PAF-AH Platelet aggregation c-myc c-fos MAP kinase Mitogen-activated kinase G1 Cell cycle PAF 11.841353591160
13208 Mirin 299953-00-7 ≥95% 2009-04-15 42.463867403315 mirin DNA damage ATM histone nuclease MRN Mre11 Rad50 Nbs1 repair 42.463867403315
10009365 MTT Cell Proliferation Assay Kit - 2007-02-15 114.533050951503 mtt-cell-proliferation-assay-kit assays kits screen measures measurements cells cellular growth factors signaling signalling molecules transcription DNA pathological cancers aging cycles progression regulatory cytokines mitogens drugs inductions inhibitors inhibits inhibitions in vitro plasma membranes formazan intracellular NAD(P)H-oxidoreductases NADPH-oxidoreductases proteins enzymes enzymatic cleavage microtiter plates tertrazolium salts mitochondrial dehydrogenases cancer cell-based assay cell based assay cba 114.533050951503
10011255 NSC 210902 51726-83-1 ≥95% 2008-09-15 3.973812154697 nsc-210902 Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 3.973812154697
13196 NSC 23766 (hydrochloride) 1177865-17-6 ≥98% 2010-07-20 18.908674033149 nsc-23766-hydrochloride 733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration Aminoquinolines angiogenesis leukemia cancers gene expression Rac1 Inhibitor 18.908674033149
13303 NSC 663284 383907-43-5 ≥98% 2010-04-01 14.270745856353 nsc-663284 Cdc25 Phosphatase Inhibitor II; DA-3003-1 dual specificity phosphatases CDC25 Cdc25A Cdc25B Cdc25C proto-oncogenes cancers inhibitors VHR PTP1B MKP-1 Cdk1 Cdk2 cells proliferation tumors inhibits inhibition Cdcs potent cell-permeable irreversible 14.270745856353
18585 (−)-Nutlin-3 - ≥98% 2008-08-06 347.018968692449 -nutlin-3 Nutlin 3a P53 cellular stress proliferation cells cycle apoptosis tumor suppressor MDM2 agents Nutlin-3 enantiomer a 347.018968692449
10009816 (+)-Nutlin-3 - ≥98% 2008-08-11 130.763991712707 -nutlin-3 Nutlin 3b p53 cellular stress proliferation cells cycle apoptosis tumer suppressor MDM2 inactive inhibitors inhibits inhibition Nutlin-3 enantiomer b 130.763991712707
13641 NVP-AEW541 (hydrochloride) - ≥98% 2010-07-28 41.979834254143 nvp-aew541-hydrochloride 475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 Pyrroles 41.979834254143
10010240 Olomoucine 101622-51-9 ≥98% 2007-09-13 11.101562746645 olomoucine inhibitors inhibits inhibition cyclin-dependent kinases cdks spinal cord injury SCI G1 cell cycle 11.101562746645
10011301 p38 MAPK Monoclonal Antibody (Clone 9F12) - 2008-05-22 3.323351749539 p38-mapk-monoclonal-antibody-clone-9f12 p38 Mitogen-activated Protein Kinase; p38 MAPKα serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC 3.323351749539
10735 Phthalazinone pyrazole Exclusive 880487-62-7 ≥98% ✓ 2011-07-27 5.267071823204 phthalazinone-pyrazole inhibitors inhibits inhibition auroras kinases cells cycle cancers centrosomes mitosis spindles cancers proliferation cells growth phosphorylation Auroroa-A Aurora-B Aurora-C A B C HCT116 HCT-116 Colo 116 HCT 116 Colo116 Colo-116 MCF7 MCF-7 MCF 7 5.267071823204
9000185 Prostaglandin A2 methyl ester Exclusive 31753-19-2 ≥98% ✓ 2010-11-08 1.523953345610 prostaglandin-a2-methyl-ester PGA2 methyl ester; Medullin methyl ester hypertension cancers lipophilic analogs PGA2 prostaglandins 1.523953345610
10011237 Protein Phosphatase 2A C subunit (human recombinant; L309 deletion) Exclusive - ✓ 2008-07-17 27.116464088398 protein-phosphatase-2a-c-subunit-human-recombinant-l309-deletion PP2A Cα; PP2A Δ309; PP2A L309 proteins phosphatases serine threonine cellular tumors enzyme kinetics regulations substrates phosphorylasion PP2As octahistidine-tag streptactin-tag active 27.116464088398
10008394 PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) - ≥98% 2007-06-11 14.764593255858 ptdins-3-p1-1-2-dioctanoyl-sodium-salt Phosphatidylinositol-3-monophosphate C-8; DOPI-3-P1 phosphatidyl inositols IP3 diacylglcerol DAG PIP1 PIP2 PIP3 transuction C phospholipase D PLC PLD signaling signalling 14.764593255858
10970 Retinoblastoma Protein (Cleaved) Monoclonal Antibody (Clone 172C1094) New - 2012-05-17 91.111111111111 retinoblastoma-protein-cleaved-monoclonal-antibody-clone-172c1094 p105-Rb; pp110; Rb; pRb tumors suppressors cells cycles regulators apoptosis cleavage caspase-3 likes proteases E2F-1 primary myeloid fetal livers bones marrow spleens cancer therapy therapies tumor-associated macrophages TAMs western blots blotting immunohistochemistry 91.111111111111
13697 (R)-MG132 Exclusive 1211877-36-9 ≥98% ✓ 2010-06-22 102.382928176796 -r-mg132 ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited 102.382928176796
10009569 (R)-Roscovitine 186692-46-6 ≥98% 2007-09-04 18.619401473296 -r-roscovitine Seliciclib cell cycle cyclin-dependent kinase cdk proliferation cancer renal disease 18.619401473296
10012628 (S)-MG132 133407-82-6 ≥98% 2009-02-18 179.218132596685 -s-mg132 Z-Leu-Leu-Leu-CHO ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO 179.218132596685
13338 SU 6656 330161-87-0 ≥95% 2009-08-04 23.932662983425 su-6656 inhibitors Src kinases Src Yes Lyn Fyn cells growth development nervous system fibrosis cancers inhibits inhibition CNS SU6656 23.932662983425
10574 Suberohydroxamic Acid 38937-66-5 ≥98% 2010-09-28 21.781184392264 suberohydroxamic-acid SBHA; Suberic bis-Hydroxamic Acid histones deacetylases HDACs inhibitors genes expression regulation epigenetics nucleosomes HDAC1 HDAC3 differentiation cells cycle arrest apoptosis cancers suberodihydroxamic acid suberoyl bishydroxamic acid inhibited inhibition Warner-Lambert Brand of Mefenamic Acid Warner Lambert Brand of Mefenamic Acid Pharmascience Brand of Mefenamic Acid First Horizon Brand of Mefenamic Acid Parke Davis Brand of Mefenamic Acid Farmasierra Brand of Mefenamic Acid Ashbourne Brand of Mefenamic Acid Pinewood Brand of Mefenamic Acid Nu-Pharm Brand of Mefenamic Acid Nu Pharm Brand of Mefenamic Acid Chemidex Brand of Mefenamic Acid Gödecke Brand of Mefenamic Acid Clonmel Brand of Mefenamic Acid Antigen Brand of Mefenamic Acid Pfizer Brand of Mefenamic Acid Apotex Brand of Mefenamic Acid Rowa Brand of Mefenamic Acid Elan Brand of Mefenamic Acid APS Brand of Mefenamic Acid PMS-Mefenamic Acid PMS Mefenamic Acid Acid Mefenaminic Mefenaminic Acid Acid Mefenamic Mefenamic Acid Forte Ponstan Ponstan Forte Apo-Mefenamic Apo Mefenamic Nu-Mefenamic Nu Mefenamic ApoMefenamic NuMefenamic Pinalgesic Contraflam Ponalgic Parkemed Ponstel Ponstan Ponalar Mefacit Pontal Ponsyl Ponmel Dysman Coslan Mefic Mefac 21.781184392264
13085 Tenovin-1 Exclusive 380315-80-0 ≥98% ✓ 2008-09-18 26.669751381215 tenovin-1 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition melonoma lymphoma 26.669751381215
13086 Tenovin-6 1011557-82-6 ≥95% 2009-02-12 42.828153117600 tenovin-6 histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition SIRTs transcription factors TFs 42.828153117600
10011619 Terbinafine (hydrochloride) 78628-80-5 ≥98% 2010-02-16 4.223204419890 terbinafine-hydrochloride antifungals squalene epoxidase antitumor tumors antiangiogenic anticancer cancers inhibitors inhibits inhibition Naphthalenes 4.223204419890
700240 Total Phosphatidic Acid Assay Kit - 2009-08-24 69.939443567482 total-phosphatidic-acid-assay-kit PA Assay Kit assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin 69.939443567482
13791 TRF2 Polyclonal Antibody - 2010-06-24 0.690607734806 trf2-polyclonal-antibody TTAGGG Repeat Binding Factor 2; TRBF2; Telomeric Repeat Binding Factor 2; TERF2 antibodies proteins TRF-2 TRF 2 factors repeat DNA binding cells apoptosis western blots blotting immunoblotting telomere WB ICC IP ChIP IF immunoprecipitation immunofluorescence immunocytochemistry cancers apoptosis 0.690607734806
10011251 TWS119 601514-19-6 ≥90% 2008-12-11 20.695616942910 tws119 inhibitors inhibits inhibition stem cells differentiation neurogenesis neuron kinases GSK-3β GSK3β TWS 119 TWS-119 20.695616942910
13722 Ubiquitin Monoclonal Antibody (Clone 5B9-B3) - 2009-12-04 2.951012891344 ubiquitin-monoclonal-antibody-clone-5b9-b3 antibodies western blots WB blotting immunoblotting ELISA ubiquitination inhibitors proteins IκBα signal transduction 2.951012891344
10010591 Wortmannin 19545-26-7 ≥98% 2008-11-21 30.065709170100 wortmannin KY 12420 phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK 30.065709170100
13604 WYE-354 New 1062169-56-5 ≥98% 2012-01-12 12.173137712297 wye-354 mTOR mTORC1 mTORC2 inhibitors inhibits inhibition PI3K cancers cells growth PTENs tumors rapamycin complex 1 2 G1 phosphatidylinositol 3-kinase α PI3Kα kinases 12.173137712297
13576 YM-201636 371942-69-7 ≥95% 2010-04-14 14.184116022099 ym-201636 PIKfyve phosphoinositide kinase PIK zinc finger domains phosphatidylinositol 3-phosphate PI3P PI(3,5)P2 membrane trafficking cytoskeleton inhibitors endosomal trafficking endosomes phagocytosis retrovirus virology adipocytes insulin glucose diabetes YM201636 YM 201636 Aminopyridines 14.184116022099
13601 ZM 447439 331771-20-1 2010-08-03 7.050110497237 zm-447439 auroras A B C kinases mitosis cytokinesis centromere inhibitors inhibits inhibition cancers Benzamides 7.050110497237
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?